Literature DB >> 20861297

Unusual life-threatening Rosai-Dorfman disease of the trachea: role of NF-κB.

Lin-Fu Zhou1, Liang Chen, Quan Zhu, Cong Wang, Hai Xu, Xue-Fan Cui, Lei-Fu Jiang, Shao-Heng He, Mao Huang, Kai-Sheng Yin.   

Abstract

Rosai-Dorfman disease (RDD) is a rare non-neoplastic histioproliferative disorder characterised by painless lymphadenopathy, low fever, high erythrocyte sedimentation rate, leucocytosis and hypergammaglobulinaemia. Overactivity of nuclear factor κB (NF-κB) is linked with inflammatory, cancerous and autoimmune diseases. The first case is described of an unusual life-threatening RDD of the trachea with no lymphadenopathy at risk of suffocation in a 39-year-old Chinese woman. A diagnosis of RDD was made following CT scans, thoracotomy and histological examination. Gel shift assay revealed an essential role for NF-κB overactivity in RDD. The patient remains well with no evidence of progression without treatment. Histological confirmation should be sought in all cases as the clinical manifestation of RDD is similar to asthma or lung carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861297     DOI: 10.1136/thx.2010.139998

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

1.  Extranodal Rosai-Dorfman Disease- a Review of Diagnostic Testing and Management.

Authors:  Imad Ud Deen; Abhinandan Chittal; Nabil Badro; Robert Jones; Christopher Haas
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-04-12

2.  Rosai-Dorfman Disease with nodal and extranodal involvements: A case report.

Authors:  Mehri Najafi-Sani; Hossein Saneian; Fatemeh Mahjoub
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

Review 3.  Tracheobronchial Involvement of Rosai-Dorfman Disease: Case Report and Review of the Literature.

Authors:  Louis Boissière; Martine Patey; Olivier Toubas; Juliette Vella-Boucaud; Jeanne-Marie Perotin-Collard; Gaëtan Deslée; Francois Lebargy; Sandra Dury
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.